Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial
figureposted on 2020-06-23, 13:47 authored by Gaoxing Zhang, Yongqiang Fan, Yumin Qiu, Zhe Zhou, Jianning Zhang, Zhichao Wang, Yuanya Liu, Xing Liu, Jun Tao
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.